News Ocular Therapeutix Eye Drug Meets Goal in Late-Stage Study by Medscape • 2015/03/11 • 0 Comments Ocular Therapeutix Inc said its lead eye drug reduced pain and inflammation in patients following cataract surgery in a late-stage trial. Reuters Health Information Full Story →